Amoxicillina

Amoxicillina may be available in the countries listed below.

Ingredient matches for Amoxicillina

Amoxicillin

Amoxicillina (DCIT) is known as Amoxicillin in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Cilox

Cilox may be available in the countries listed below.

Ingredient matches for Cilox

Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Cilox in the following countries:

• Norway

International Drug Name Search

Capasal Shampoo

Capasal Shampoo may be available in the countries listed below.

Ingredient matches for Capasal Shampoo

Salicylic Acid

Salicylic Acid is reported as an ingredient of Capasal Shampoo in the following countries:

• Ireland

International Drug Name Search

Nycoplus C-vitamin

Nycoplus C-vitamin may be available in the countries listed below.

Ingredient matches for Nycoplus C-vitamin

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Nycoplus C-vitamin in the following countries:

• Norway

International Drug Name Search

Oftalgesic

Oftalgesic may be available in the countries listed below.

Ingredient matches for Oftalgesic

Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Oftalgesic in the following countries:

• Dominican Republic

International Drug Name Search

Uniwarfin

Uniwarfin may be available in the countries listed below.

Ingredient matches for Uniwarfin

Warfarin

Warfarin sodium salt (a derivative of Warfarin) is reported as an ingredient of Uniwarfin in the following countries:

• India

International Drug Name Search

Gabitril

Gabitril is a brand name of tiagabine, approved by the FDA in the following formulation(s):

GABITRIL (tiagabine hydrochloride - tablet; oral)

• 
  Manufacturer: CEPHALON
  
  Approval date: September 30, 1997
  
  Strength(s): 12MG, 16MG, 4MG ^[RLD][AB]


• 
  Manufacturer: CEPHALON
  
  Approval date: April 16, 1999
  
  Strength(s): 2MG ^[AB]

Has a generic version of Gabitril been approved?

A generic version of Gabitril has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Gabitril and have been approved by the FDA:

tiagabine hydrochloride tablet; oral

• 
  Manufacturer: SUN PHARM INDS
  
  Approval date: November 4, 2011
  
  Strength(s): 2MG ^[AB], 4MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Gabitril. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  N-(butenyl substituted) azaheterocyclic carboxylic acids
  Patent 5,010,090
  Issued: April 23, 1991
  Inventor(s): Gronvald; Frederik C. & Braestrup; Claus
  Assignee(s): Novo Nordisk A/S.
  1-Aminobut-3-en derivatives having optionally substituted furanyl, thienyl, pyridyl and/or pyrrolyl in the 4-position and 3-carboxypiperidin-1-yl, 3-carboxytetrahydropyrid-1-yl or 3 carboxymethylpyrrolidin-1-yl in the 1-position potentiate GABA-ergic neurotransmission.
  
  Patent expiration dates:
  
  
  • September 30, 2011
    
  
  



• 
  Crystalline Tiagabine monohydrate, its preparation and use
  Patent 5,354,760
  Issued: October 11, 1994
  Inventor(s): Petersen; Henning & Nielsen; Peter & Cain; Michael & Patel; Subhash
  Assignee(s): Novo Nordisk A/S
  The invention provides crystalline Tiagabine hydrochloride monohydrate, process for its preparation, compositions containing the same and its therapeutic use as anti-epileptic agent.
  
  Patent expiration dates:
  
  
  • March 24, 2012
    
  
  



• 
  Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
  Patent 5,866,590
  Issued: February 2, 1999
  Inventor(s): Svensson; J.o slashed.rgen Ryhl & Nygaard; Lars & Andersen; Tina Meinertz & Weibel; Helle & Hjorth; Thyge Borup
  Assignee(s): Novo Nordisk A/S
  The present invention provides a new stable pharmaceutical composition containing tiagabine hydrochloride as active ingredient.
  
  Patent expiration dates:
  
  
  • April 29, 2016
    
  
  



• 
  Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
  Patent 5,958,951
  Issued: September 28, 1999
  Inventor(s): Ahrndt; Preben & Petersen; Henning B.o slashed.rge & Chang; Vincent H. & Allen; Kimberly Ann & Cain; Michael H.
  Assignee(s): Novo Nordiskials
  The present invention provides R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride in its pure and stable anhydrous form.
  
  Patent expiration dates:
  
  
  • June 10, 2017
    
  
  

See also...

• Gabitril Consumer Information (Wolters Kluwer)
• Gabitril Consumer Information (Cerner Multum)
• Gabitril Advanced Consumer Information (Micromedex)
• Gabitril AHFS DI Monographs (ASHP)
• Tiagabine Consumer Information (Wolters Kluwer)
• Tiagabine Consumer Information (Cerner Multum)
• Tiagabine Advanced Consumer Information (Micromedex)
• Tiagabine Hydrochloride AHFS DI Monographs (ASHP)